10-K

Company

Citius Pharmaceuticals, Inc.

Filed

February 6, 2014

Period of Report

September 30, 2013

Accession Number

0001185185-14-000261

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →